Clinical studies support these findings, as newly diagnosed T2DM patients show lower circulating IL-22 levels (Asadikaram et al., 2018), suggesting that lower IL-22 levels may be associated with higher T2DM risk. This evidence concerns the gene IL22 and type 2 diabetes mellitus.